Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 13, 2019

SELL
$12.43 - $28.91 $565,652 - $1.32 Million
-45,507 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
$10.57 - $19.29 $202,933 - $370,348
-19,199 Reduced 29.67%
45,507 $542,000
Q3 2018

Nov 13, 2018

SELL
$17.31 - $29.82 $16,877 - $29,074
-975 Reduced 1.48%
64,706 $1.21 Million
Q2 2018

Aug 10, 2018

BUY
$6.85 - $38.49 $10,144 - $57,003
1,481 Added 2.31%
65,681 $1.84 Million
Q1 2018

May 14, 2018

BUY
$8.34 - $12.5 $535,428 - $802,500
64,200 New
64,200 $580,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $707M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track United Services Automobile Association Portfolio

Follow United Services Automobile Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

News

Stay updated on United Services Automobile Association with notifications on news.